32.1 C
Saturday, June 15, 2024

Russia approves clinical trials of modified Sputnik V vaccine


Share post:


Moscow: Russia’s Ministry of Health has authorised clinical trials of a modified version of Russia’s Sputnik V vaccine against COVID-19, the data from the registry of approved clinical trials has shown.

“The goal of the clinical study: to evaluate the safety, reactogenicity and immunogenicity of the Gam-COVID-Vac vector vaccine [Sputnik V] for the prevention of coronavirus infection caused by the SARS-CoV-2 virus with a modified antigenic profile in adult volunteers,” the line in the registry has shown.

The clinical study will be completed on December 31, 2024. As many as 100 volunteers are expected to participate in the trials, according to the registry.

An authorisation has also been issued to carry out clinical trials of a modified coronavirus vaccine for children aged 12-17, and the trials will be completed on December 31, 2024, the registry has shown.

Alexander Gintsburg, the director of Moscow-based Gamaleya National Center for Epidemiology and Microbiology, which developed the Sputnik V vaccine, told Sputnik in April that vaccines against COVID-19 should be modified every 9-10 months to be effective.

Related articles

Delhi LG Sanctions Prosecution of Arundhati Roy under Anti-Terror Law

In a significant development, the Lieutenant Governor of Delhi, VK Saxena, has sanctioned the prosecution of noted author...

Pope Francis and Narendra Modi: Two Global Change Managers

In an era marked by profound social, political, and environmental challenges, leadership that transcends national boundaries and addresses...

The Quest for Justice: Remembering Sushant Singh Rajput

On June 14, 2020, the world was shocked by the tragic death of Sushant Singh Rajput, a beloved...

We cannot even afford to give gloves to garbage collectors in Goa

In the picturesque state of Goa, known for its pristine beaches and vibrant culture, there lies an unseen...